LYMPH LIGHT

GOAL

Evaluation of the efficacy of photobiomodulation therapy (PBMT) in the management of breast cancer-related lymphedema.

STUDY DESIGN

Placebo-controlled, randomized trial with breast cancer patients who get diagnosed with lymphedema after they completed their breast cancer treatment. This triall will start in January 2021.

Control group (n=52)	PBM group (n=52)
Manual lymphatic drainage (2x/week)	Manual lymphatic drainage in combination with PBMT (2x/week)

STUDY RESULTS

No preliminary results are available. 

PUBLICATIONS

 

PARTNERS